An LC-MS–guided AI enabled serum molecule-interpretable SERS platform for exploratory metabolomic analysis in Alzheimer's disease
Analytica Chimica Acta · 2026-08 · 1411 · 345637
DOI: 10.1016/j.aca.2026.345637 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytica Chimica Acta, 2026-08. Verfasst von Yanling Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Harbin Medical University, Harbin, 150081, China; The Heilongjiang Provincial Joint Laboratory of Basic Medicine an…. Hauptthemen laut MEDLINE: Alzheimer Disease, Spectrum Analysis, Raman, Metabolomics, Artificial Intelligence. Die Arbeit nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Heilongjiang Province Natural Science Foundation, National Key Research and Development Program of China.
Themen: Demenz
Abstract (Originalsprache)
Label-free surface-enhanced Raman spectroscopy (SERS) offers a promising avenue for rapid metabolic phenotyping in complex biofluids, yet its translational potential is hindered by the challenge of deconvoluting overlapping spectral contributions and identifying specific metabolite signatures. Herein, we report a liquid chromatography-mass spectrometry (LC-MS)-guided AI enabled serum molecule-interpretable SERS Platform, termed AMI-SERS, which integrates SERS, untargeted metabolomics and machine learning (ML) for Alzheimer's disease (AD) patient serum exploratory metabolic profiling. ML has achieved excellent classification performance with an accuracy of 96.67% under leave-one-out cross-validation. A novel multi-source matching algorithm was devised to trace dominant spectral features directly to specific metabolite changes, uncovering hypoxanthine as a key pre-analytical confounder and nominating adenine as a potential AD biomarker. However, due to the limited sample size, these results are only applicable to exploratory analysis. In conclusion, the AMI-SERS platform establishes a molecular-resolvable, LC-MS-interpretable AI methodological framework for exploratory serum metabolomics and its clinical applicability requires large-scale independent validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medical Sciences, Harbin Medical University, Harbin, 150081, China; The Heilongjiang Provincial Joint Laboratory of Basic Medicine and Multiple Organ System Diseases (International Cooperation), Harbin,…
- Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150086, China.
- Department of Laboratory Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150001, China.
- NHC and CAMS Key Laboratory of Molecular Probe and Targeted Theranostics, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150001, China. Electronic address: wuxiaohong@hrbmu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Heilongjiang Province Natural Science Foundation
- National Key Research and Development Program of China
Zitieren
APA
Wang, Y., Zhang, C., Liu, T., Li, Q., Guan, X., Hu, Y., Cao, B., Wu, X., Zhou, Q., & Cui, F. (2026). An LC-MS–guided AI enabled serum molecule-interpretable SERS platform for exploratory metabolomic analysis in Alzheimer's disease. Analytica Chimica Acta, 1411, 345637. https://doi.org/10.1016/j.aca.2026.345637
Vancouver
Wang Y, Zhang C, Liu T, Li Q, Guan X, Hu Y, et al. An LC-MS–guided AI enabled serum molecule-interpretable SERS platform for exploratory metabolomic analysis in Alzheimer's disease. Analytica Chimica Acta. 2026;1411:345637. doi:10.1016/j.aca.2026.345637
BibTeX
@article{Wang2026,
author = {Wang, Yanling and Zhang, Chi and Liu, Tong and Li, Qingsong and Guan, Xue and Hu, Yutian and Cao, Bo and Wu, Xiaohong and Zhou, Qin and Cui, Feiyun},
title = {An LC-MS–guided AI enabled serum molecule-interpretable SERS platform for exploratory metabolomic analysis in Alzheimer's disease},
journal = {Analytica Chimica Acta},
year = {2026},
volume = {1411},
pages = {345637},
doi = {10.1016/j.aca.2026.345637}
}
EUVIMED